S-8 S-8 EX-FILING FEES 0001401040 DiaMedica Therapeutics Inc. N/A Fees to be Paid 0001401040 2026-08-10 2026-08-10 0001401040 1 2026-08-10 2026-08-10 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

DiaMedica Therapeutics Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Shares, no par value Other 3,500,000 $ 6.615 $ 23,152,500.00 0.0001381 $ 3,197.36

Total Offering Amounts:

$ 23,152,500.00

$ 3,197.36

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 3,197.36

Offering Note

1

Amount Registered represents common shares, no par value ("Common Shares"), issuable pursuant to the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan (the "Plan"). Pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers any additional Common Shares that become issuable under the Plan by reason of any stock split, stock dividend or other similar transaction effected without the receipt of consideration that results in an increase in the number of outstanding Common Shares. Proposed Maximum Offe